Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma.

× No keyword cloud information.

9 in total

Review 1. Neurotoxicity of biologically targeted agents in pediatric cancer trials.

Authors: Elizabeth M Wells; Amulya A Nageswara Rao; Joseph Scafidi; Roger J Packer
Journal: Pediatr Neurol Date: 2012-04 Impact factor: 3.372

2. Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.

Authors: Erin G Reid; David Looney; Frank Maldarelli; Ariela Noy; David Henry; David Aboulafia; Juan Carlos Ramos; Joseph Sparano; Richard F Ambinder; Jeannette Lee; Ethel Cesarman; Sara Yahyaei; Ronald Mitsuyasu; William Wachsman
Journal: Blood Adv Date: 2018-12-26

3. Modified toxicity probability interval design: a safer and more reliable method than the 3 + 3 design for practical phase I trials.

Authors: Yuan Ji; Sue-Jane Wang
Journal: J Clin Oncol Date: 2013-04-08 Impact factor: 44.544

Review 4. Advances in the treatment of relapsed or refractory Hodgkin's lymphoma.

Authors: Radhakrishnan Ramchandren
Journal: Oncologist Date: 2012-03-02

Review 5. Pharmacotherapeutic Management of Pediatric Lymphoma.

Authors: Christine Mauz-Körholz; Natascha Ströter; Julia Baumann; Ante Botzen; Katharina Körholz; Dieter Körholz
Journal: Paediatr Drugs Date: 2018-02 Impact factor: 3.022

6. Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial.

Authors: Meghan Karuturi; Anas Younes; Luis Fayad; Larry Kwak; Barbara Pro; Jatin Shah; Yasuhiro Oki; Rinata Simien; Mary Joy Liboon; Toni Hutto; Lei Feng; Sandra Horowitz; Yago Nieto; Paolo Anderlini; Amin Alousi; Uday Popat; L Jeffrey Medeiros; Roberto Miranda; Michelle Fanale
Journal: Leuk Lymphoma Date: 2015-03-25

Review 7. Customized targeted therapy in Hodgkin lymphoma: hype or hope?

Authors: Catherine Diefenbach; Ranjana Advani
Journal: Hematol Oncol Clin North Am Date: 2014-02 Impact factor: 3.722

Review 8. Approaches to modernize the combination drug development paradigm.

Authors: Daphne Day; Lillian L Siu
Journal: Genome Med Date: 2016-10-28 Impact factor: 11.117

9. Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies.

Authors: Theodoros Karantanos; Ioannis Politikos; Vassiliki A Boussiotis
Journal: Blood Lymphat Cancer Date: 2017-05-09

9 in total